Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The aim of our study is to compare the incidence of PNAC in newborns receiving cyclic versus continuous parenteral nutrition (PN) in those newborns who need prolonged PN. The secondary aims are to compare incidence of sepsis and catheter related sepsis, mean length of hospital stay, mortality, nutritional status at two years of chronological age and predisposing factors to the development of parenteral nutrition associated cholestasis (PNAC) between the two groups, and to evaluate the adverse effects of the method of cycling used.
This was a single-center, prospective randomized not blinded study was conducted in a level 3 neonatal intensive care unit from July 2010 to January 2015. Infants with hemodynamic instability until a stable situation, congenital hepatic disease, preterm infants with diagnosis of respiratory distress syndrome or persistent ductus arteriosus and lack of authorization from the parents or guardians were excluded.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Intervention: Cyclic parenteral nutrition Cohort | Experimental | All newborn who were included in the study to receive cyclic parenteral nutrition (within 24 hours). The parenteral nutrition was stopped for one hour the first day until 4 hours in preterm infants and 6 hours in term neonates. |
|
| Control: Continuous parenteral nutrition | No Intervention | All newborn who were included in the study to receive continuous parenteral nutrition (24 hours). The parenteral nutrition was given by a central line in 24 hours with a basal flow |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Cyclic parenteral nutrition | Procedure | Cyclic parenteral nutrition was provided according to a method described by Longhurst et al. Patients were initially cycled of PN for 1 hour per day with increased rate of 1 hour with a maximum time out of PN of 4 hours for preterm babies < 37 weeks GA and 6 hours for term newborns. Glucose was monitored at half the time without PN to detect the hypoglycemia. |
| Measure | Description | Time Frame |
|---|---|---|
| % patients with parenteral nutrition associated cholestasis (PNAC) | The incidence of parenteral nutrition associated cholestasis in newborns receiving cyclic versus continuous PN in those newborns who need prolonged PN. | through study completion, an average of 1 year |
| Measure | Description | Time Frame |
|---|---|---|
| Incidence of sepsis | The percentage of patients who was diagnosed of sepsis in newborns receiving cyclic versus continuous PN in those newborns who need prolonged PN. | through study completion, an average of 1 year |
| Incidence of catheter related sepsis (CRS) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Nelia Navarro patiño | Madrid | Madrid | 28007 | Spain |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 10903005 | Background | Angelico M, Della Guardia P. Review article: hepatobiliary complications associated with total parenteral nutrition. Aliment Pharmacol Ther. 2000 May;14 Suppl 2:54-7. doi: 10.1046/j.1365-2036.2000.014s2054.x. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D002780 | Cholestasis, Intrahepatic |
| ID | Term |
|---|---|
| D002779 | Cholestasis |
| D001649 | Bile Duct Diseases |
| D001660 | Biliary Tract Diseases |
| D004066 | Digestive System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
The percentage of patients who was diagnosed of CRS in newborns receiving cyclic versus continuous PN in those newborns who need prolonged PN. |
| through study completion, an average of 1 year |
| Mean length of hospital stay | The mean length of hospital stay in newborns receiving cyclic versus continuous PN in those newborns who need prolonged PN. | through study completion, an average of 1 year |
| Nutrition factors to the development of PNAC | total days on enteral nutrition in newborns receiving cyclic versus continuous PN in those newborns who need prolonged PN. | through study completion, an average of 1 year |
| Nutrition factors to the development of PNAC | total days on parenteral nutrition in newborns receiving cyclic versus continuous PN in those newborns who need prolonged PN. | through study completion, an average of 1 year |
| Anticholestatic drugs | % of patients with anticholestatic drug in newborns receiving cyclic versus continuous PN in those newborns who need prolonged PN. | through study completion, an average of 1 year |
| Anticholestatic drugs | days of duration of treatment with anticholestatic drug in newborns receiving cyclic versus continuous PN in those newborns who need prolonged PN. | through study completion, an average of 1 year |
| Adverse effects of the method of cycling used | Percentage of adverse effects, type of adverse affects | through study completion, an average of 1 year |
| Mortality | the percentage of patients who died and the cause of death | through study completion, an average of 1 year |
| Mortality | The cause of death | through study completion, an average of 1 year |
| D008107 |
| Liver Diseases |